CN1081765A - 用于测定血红蛋白衍生物的免疫方法 - Google Patents
用于测定血红蛋白衍生物的免疫方法 Download PDFInfo
- Publication number
- CN1081765A CN1081765A CN93104037A CN93104037A CN1081765A CN 1081765 A CN1081765 A CN 1081765A CN 93104037 A CN93104037 A CN 93104037A CN 93104037 A CN93104037 A CN 93104037A CN 1081765 A CN1081765 A CN 1081765A
- Authority
- CN
- China
- Prior art keywords
- hemoglobin
- content
- sample
- derivatives
- immunoassay
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 230000003053 immunization Effects 0.000 title description 2
- 238000002649 immunization Methods 0.000 title description 2
- 102000001554 Hemoglobins Human genes 0.000 claims abstract description 108
- 108010054147 Hemoglobins Proteins 0.000 claims abstract description 108
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 52
- 210000004369 blood Anatomy 0.000 claims abstract description 40
- 239000008280 blood Substances 0.000 claims abstract description 40
- 230000002949 hemolytic effect Effects 0.000 claims abstract description 27
- 239000003599 detergent Substances 0.000 claims description 37
- 238000012360 testing method Methods 0.000 claims description 31
- 239000011535 reaction buffer Substances 0.000 claims description 27
- 238000003018 immunoassay Methods 0.000 claims description 24
- 206010018910 Haemolysis Diseases 0.000 claims description 17
- 230000008588 hemolysis Effects 0.000 claims description 17
- 238000005259 measurement Methods 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 238000002835 absorbance Methods 0.000 claims description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 8
- 239000007987 MES buffer Substances 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 102000035122 glycosylated proteins Human genes 0.000 claims description 4
- 108091005608 glycosylated proteins Proteins 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 230000007797 corrosion Effects 0.000 claims 1
- 238000005260 corrosion Methods 0.000 claims 1
- 230000010534 mechanism of action Effects 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 abstract description 6
- 108091005995 glycated hemoglobin Proteins 0.000 abstract description 5
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 13
- 238000003556 assay Methods 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 9
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- AWDBHOZBRXWRKS-UHFFFAOYSA-N tetrapotassium;iron(6+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+6].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] AWDBHOZBRXWRKS-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008118 PEG 6000 Substances 0.000 description 4
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- KFGWEMFTDGCYSK-UHFFFAOYSA-N 3-methyl-1,2-thiazole 1-oxide Chemical compound CC=1C=CS(=O)N=1 KFGWEMFTDGCYSK-UHFFFAOYSA-N 0.000 description 3
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- -1 amine bromide Chemical class 0.000 description 3
- XVBRCOKDZVQYAY-UHFFFAOYSA-N bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003219 hemolytic agent Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000005375 photometry Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- CKRJGDYKYQUNIM-UHFFFAOYSA-N 3-fluoro-2,2-dimethylpropanoic acid Chemical compound FCC(C)(C)C(O)=O CKRJGDYKYQUNIM-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 241001460678 Napo <wasp> Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- RCLDHCIEAUJSBD-UHFFFAOYSA-N 6-(6-sulfonaphthalen-2-yl)oxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=CC2=CC(OC3=CC4=CC=C(C=C4C=C3)S(=O)(=O)O)=CC=C21 RCLDHCIEAUJSBD-UHFFFAOYSA-N 0.000 description 1
- 238000003691 Amadori rearrangement reaction Methods 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- CXRFDZFCGOPDTD-UHFFFAOYSA-M Cetrimide Chemical compound [Br-].CCCCCCCCCCCCCC[N+](C)(C)C CXRFDZFCGOPDTD-UHFFFAOYSA-M 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000004523 agglutinating effect Effects 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 108700042971 cyanomethemoglobin Proteins 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- ZJZXSOKJEJFHCP-UHFFFAOYSA-M lithium;thiocyanate Chemical compound [Li+].[S-]C#N ZJZXSOKJEJFHCP-UHFFFAOYSA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical group O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/723—Glycosylated haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4206932A DE4206932A1 (de) | 1992-03-05 | 1992-03-05 | Immunologische methode zur bestimmung eines haemoglobinderivates |
| DEP4206932.7 | 1992-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1081765A true CN1081765A (zh) | 1994-02-09 |
Family
ID=6453281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93104037A Pending CN1081765A (zh) | 1992-03-05 | 1993-03-04 | 用于测定血红蛋白衍生物的免疫方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5541117A (enExample) |
| EP (1) | EP0559164B1 (enExample) |
| JP (1) | JP2637677B2 (enExample) |
| KR (1) | KR930020162A (enExample) |
| CN (1) | CN1081765A (enExample) |
| AT (1) | ATE193378T1 (enExample) |
| AU (1) | AU652092B2 (enExample) |
| CA (1) | CA2090981C (enExample) |
| CZ (1) | CZ29193A3 (enExample) |
| DE (2) | DE4206932A1 (enExample) |
| DK (1) | DK0559164T3 (enExample) |
| ES (1) | ES2148190T3 (enExample) |
| FI (1) | FI930975A7 (enExample) |
| HR (1) | HRP930253A2 (enExample) |
| HU (1) | HUT70463A (enExample) |
| IL (1) | IL104902A0 (enExample) |
| NO (1) | NO930770L (enExample) |
| NZ (1) | NZ247054A (enExample) |
| PL (1) | PL297915A1 (enExample) |
| PT (1) | PT559164E (enExample) |
| SI (1) | SI9300108A (enExample) |
| SK (1) | SK14993A3 (enExample) |
| ZA (1) | ZA931533B (enExample) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101493467A (zh) * | 2008-01-25 | 2009-07-29 | 上海伊思柏生物科技有限公司 | 定量测定糖化蛋白质的方法 |
| CN100593117C (zh) * | 2001-04-24 | 2010-03-03 | 阿克西斯-希尔德公司 | 血红蛋白测定 |
| CN101755207A (zh) * | 2007-10-30 | 2010-06-23 | 松下电器产业株式会社 | 血红蛋白及血红蛋白衍生物的测定方法、测定试剂盒 |
| CN102640002A (zh) * | 2009-05-20 | 2012-08-15 | 瑞莱诊断体系股份有限公司 | 检测糖化血红蛋白百分比的系统和方法 |
| CN101160527B (zh) * | 2005-04-14 | 2013-04-03 | 松下电器产业株式会社 | 血红蛋白衍生物的测定方法、该法中使用的试剂组合物、测定试剂盒、分析设备以及分析系统 |
| CN104062430A (zh) * | 2014-06-30 | 2014-09-24 | 洛阳普莱柯万泰生物技术有限公司 | 一种用于检测样品中流感病毒的试剂盒及其检测方法和应用 |
| CN109154623A (zh) * | 2015-12-30 | 2019-01-04 | P·瓦尔霍 | 用于确定血液样本中的HbA1c的量的方法 |
| CN110702894A (zh) * | 2019-10-10 | 2020-01-17 | 南京欧凯生物科技有限公司 | 一种直接测定糖化血红蛋白含量的检测方法 |
| CN114441750A (zh) * | 2020-10-30 | 2022-05-06 | 深圳市瑞图生物技术有限公司 | 用于全血样本免疫五项测定的试剂、试剂盒、方法和装置 |
| CN115867805A (zh) * | 2020-03-31 | 2023-03-28 | 乌普卡拉公司 | 用于快速检测生物样品中的目标分析物的装置和方法 |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739037A (en) * | 1992-09-29 | 1998-04-14 | Drew Scientific Limited | Process for eliminating labile glycohaemoglobin from a sample |
| US5610076A (en) * | 1994-04-29 | 1997-03-11 | Alteon Inc. | Method for detecting hemoglobin advanced glycosylation endproducts |
| FR2721112B1 (fr) * | 1994-06-13 | 1996-08-14 | Gks Technologies | Dispositif de diagnostic rapide de toute molécule glyquée et procédé de mise en Óoeuvre. |
| JP3150857B2 (ja) * | 1994-10-19 | 2001-03-26 | 富士写真フイルム株式会社 | グリコヘモグロビン含有比測定用分析要素及び分析方法 |
| EP0729031A1 (en) * | 1995-02-24 | 1996-08-28 | F. Hoffmann-La Roche Ag | Set of reagents determining the content of total haemoglobin |
| JP3269765B2 (ja) | 1995-12-14 | 2002-04-02 | 富士写真フイルム株式会社 | ヘモグロビン誘導体の免疫学的測定方法及びその方法に用いる処理試薬 |
| JP3551678B2 (ja) * | 1996-03-14 | 2004-08-11 | 東ソー株式会社 | ヘモグロビンA1cの測定法及びキット |
| US6855562B1 (en) * | 1996-07-30 | 2005-02-15 | Horiba, Ltd. | Immunoassay method for lyzed whole blood |
| JP3249919B2 (ja) * | 1996-07-30 | 2002-01-28 | 株式会社堀場製作所 | 免疫測定方法 |
| US5858794A (en) * | 1997-05-13 | 1999-01-12 | Bayer Corporation | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers |
| DE69819996T2 (de) * | 1997-09-27 | 2004-09-02 | Horiba Ltd. | Gerät für die Zählung von Blutzellen und zur immunologischen Bestimmung unter Verwendung von Vollblut |
| US6485923B1 (en) | 2000-02-02 | 2002-11-26 | Lifescan, Inc. | Reagent test strip for analyte determination having hemolyzing agent |
| WO2002021142A1 (en) * | 2000-09-07 | 2002-03-14 | Wako Pure Chemical Industries, Ltd. | Method of quantifying total hemoglobin and glycohemoglobin |
| AU2003291250A1 (en) * | 2002-11-05 | 2004-06-07 | Therasense, Inc. | Assay device, system and method |
| CA2527199C (en) * | 2003-05-27 | 2011-11-22 | Mitsubishi Kagaku Iatron, Inc. | Immunochromatographic method |
| US7659107B2 (en) * | 2003-09-23 | 2010-02-09 | Epinex Diagnostics, Inc. | Rapid test for glycated albumin |
| BRPI0415886A (pt) * | 2003-10-29 | 2007-01-09 | Mec Dynamics Corp | tiras descartáveis e método de determinação da porcentagem de hbalc na hemoglobina |
| US7150995B2 (en) | 2004-01-16 | 2006-12-19 | Metrika, Inc. | Methods and systems for point of care bodily fluid analysis |
| US7541190B2 (en) * | 2005-02-07 | 2009-06-02 | Beckman Coulter, Inc. | Method of measurement of cellular hemoglobin |
| JP4989628B2 (ja) * | 2006-03-24 | 2012-08-01 | アークレイ株式会社 | グリコヘモグロビン濃度測定方法および濃度測定装置 |
| US8268625B2 (en) * | 2006-03-24 | 2012-09-18 | Arkray, Inc. | Method of measuring glycated hemoglobin concentration and concentration measuring apparatus |
| US20100012049A1 (en) * | 2006-04-12 | 2010-01-21 | Jms Co., Ltd | Cavitation heating system and method |
| EP2047272B1 (en) | 2006-07-29 | 2014-10-22 | i-Sens, Inc. | Electrochemical determination system of glycated proteins |
| JP4437216B2 (ja) * | 2007-01-30 | 2010-03-24 | アークレイ株式会社 | フェノチアジン誘導体色素の検出方法およびそれに用いる発色剤試薬 |
| KR101005559B1 (ko) * | 2008-07-15 | 2011-01-05 | 주식회사 아이센스 | 바이오센서를 이용한 단백질 측정 장치 |
| WO2010009459A1 (en) * | 2008-07-18 | 2010-01-21 | Bayer Healthcare Llc | Methods, devices, and systems for glycated hemoglobin analysis |
| JP5574977B2 (ja) | 2008-12-11 | 2014-08-20 | 積水メディカル株式会社 | 糖化ヘモグロビン含有試料の前処理法 |
| US20100167306A1 (en) * | 2008-12-26 | 2010-07-01 | Henry John Smith | Rapid test for glycated albumin in saliva |
| KR101810264B1 (ko) * | 2010-03-31 | 2017-12-18 | 세키스이 메디칼 가부시키가이샤 | 헤모글로빈류의 분석 방법 |
| JP5906604B2 (ja) * | 2011-08-11 | 2016-04-20 | 東洋紡株式会社 | 全血検体の成分測定方法 |
| KR101207418B1 (ko) | 2012-02-10 | 2012-12-04 | 주식회사 아이센스 | 효소법을 이용하는 당화혈색소 정량분석용 용혈시약 조성물 |
| CN106461682B (zh) | 2014-05-06 | 2018-09-21 | 德赛诊断系统有限公司 | HbA1c的酶促测定 |
| WO2020054572A1 (ja) * | 2018-09-12 | 2020-03-19 | 積水メディカル株式会社 | ヘモグロビン類測定用試薬及びヘモグロビン類の測定方法 |
| CN112067566A (zh) * | 2020-08-28 | 2020-12-11 | 南开大学 | 一种用于糖化血红蛋白定量分析的比色传感器 |
| CN113984689B (zh) * | 2021-10-25 | 2023-11-03 | 中元汇吉生物技术股份有限公司 | 一种测定谷胱甘肽还原酶的试剂盒 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4247533A (en) * | 1978-05-01 | 1981-01-27 | The Rockefeller University | Hemoglobin A1c radioimmunoassay |
| US4200435A (en) * | 1978-12-26 | 1980-04-29 | Abbott Laboratories | Determination of glycosylated hemoglobin in blood |
| JPS5861465A (ja) * | 1981-10-07 | 1983-04-12 | Mitsubishi Chem Ind Ltd | 血液の分析方法 |
| US4478744A (en) * | 1982-01-25 | 1984-10-23 | Sherwood Medical Company | Method of obtaining antibodies |
| HU186976B (en) * | 1982-10-01 | 1985-10-28 | Reanal Finomvegyszergyar | Process for determation of glucose containt of glucolized in non-ensimatic way proteins and reagent lutes for this process |
| US4529705A (en) * | 1983-06-06 | 1985-07-16 | Coulter Electronics, Inc. | Reagent for combined diluting and lysing whole blood |
| US4727036A (en) * | 1985-08-08 | 1988-02-23 | Molecular Diagnostics, Inc. | Antibodies for use in determining hemoglobin A1c |
| US4658022A (en) * | 1985-08-08 | 1987-04-14 | Molecular Diagnostics, Inc. | Binding of antibody reagents to denatured protein analytes |
| CA1339952C (en) * | 1984-10-29 | 1998-07-14 | William J. Knowles | Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto |
| US4647654A (en) * | 1984-10-29 | 1987-03-03 | Molecular Diagnostics, Inc. | Peptides useful in preparing hemoglobin A1c immunogens |
| JPS61148369A (ja) * | 1984-12-06 | 1986-07-07 | テクニコン・インストウルメンツ・コーポレイシヨン | シアニドを含まないヘモグロビン試薬 |
| DK145385D0 (da) * | 1985-03-29 | 1985-04-01 | Novo Industri As | Monoklonalt antistof til immunkemisk analyse |
| DE3532868A1 (de) * | 1985-09-14 | 1987-03-26 | Boehringer Mannheim Gmbh | Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin sowie hierzu geeignete verbindungen und verfahren zu deren herstellung |
| US4806468A (en) * | 1987-02-05 | 1989-02-21 | Becton, Dickinson And Company | Measurement of glycosylated hemoglobin by immunoassay |
| US4861728A (en) * | 1987-07-24 | 1989-08-29 | Becton, Dickinson And Company | Immunoassay of glycosylated hemoglobin using a labeled boron reagent |
| DE3733084A1 (de) * | 1987-09-30 | 1989-04-13 | Boehringer Mannheim Gmbh | Testtraeger zur analytischen bestimmung eines bestandteils einer koerperfluessigkeit |
| US4970171A (en) * | 1987-11-09 | 1990-11-13 | Miles Inc. | Denaturant reagents for convenient determination of hemoglobin derivatives in blood |
| JP2619900B2 (ja) * | 1988-01-27 | 1997-06-11 | 東亜医用電子株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬および方法 |
| NO890029D0 (no) * | 1989-01-04 | 1989-01-04 | Axis Research | Nye modifiserte peptider og proteiner for in vitro diagnoser (diabetes). |
| IL94724A (en) * | 1989-07-13 | 1994-02-27 | Miles Inc | Decomposition of red blood cells and denaturation of hemoglobin by the use of lithium salts |
| JP2836865B2 (ja) * | 1989-10-23 | 1998-12-14 | 東亜医用電子株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬 |
| JP2891302B2 (ja) * | 1990-03-01 | 1999-05-17 | シスメックス株式会社 | 血液中の白血球およびヘモグロビンの測定用試薬 |
| US5242832A (en) * | 1990-03-01 | 1993-09-07 | Toa Medical Electronics Co., Ltd. | Reagent for measurement of leukocytes and hemoglobin in blood |
| DE69121456T2 (de) * | 1990-05-09 | 1996-12-19 | Hoffmann La Roche | Stabilisiertes Harnsäurereagens |
| DE4135542A1 (de) * | 1991-10-28 | 1993-04-29 | Boehringer Mannheim Gmbh | Lagerfaehige proteinloesungen |
-
1992
- 1992-03-05 DE DE4206932A patent/DE4206932A1/de not_active Withdrawn
-
1993
- 1993-02-26 CZ CZ93291A patent/CZ29193A3/cs unknown
- 1993-03-01 AU AU33871/93A patent/AU652092B2/en not_active Ceased
- 1993-03-01 SK SK14993A patent/SK14993A3/sk unknown
- 1993-03-01 IL IL104902A patent/IL104902A0/xx unknown
- 1993-03-02 PL PL29791593A patent/PL297915A1/xx unknown
- 1993-03-03 HR HR930253A patent/HRP930253A2/hr not_active Application Discontinuation
- 1993-03-03 DE DE59310046T patent/DE59310046D1/de not_active Expired - Lifetime
- 1993-03-03 DK DK93103349T patent/DK0559164T3/da active
- 1993-03-03 PT PT93103349T patent/PT559164E/pt unknown
- 1993-03-03 AT AT93103349T patent/ATE193378T1/de active
- 1993-03-03 EP EP93103349A patent/EP0559164B1/de not_active Expired - Lifetime
- 1993-03-03 NZ NZ247054A patent/NZ247054A/en not_active IP Right Cessation
- 1993-03-03 NO NO93930770A patent/NO930770L/no unknown
- 1993-03-03 ES ES93103349T patent/ES2148190T3/es not_active Expired - Lifetime
- 1993-03-04 ZA ZA931533A patent/ZA931533B/xx unknown
- 1993-03-04 CA CA002090981A patent/CA2090981C/en not_active Expired - Lifetime
- 1993-03-04 FI FI930975A patent/FI930975A7/fi unknown
- 1993-03-04 HU HU9300596A patent/HUT70463A/hu unknown
- 1993-03-04 US US08/026,464 patent/US5541117A/en not_active Expired - Lifetime
- 1993-03-04 CN CN93104037A patent/CN1081765A/zh active Pending
- 1993-03-05 KR KR1019930003336A patent/KR930020162A/ko not_active Ceased
- 1993-03-05 JP JP5045130A patent/JP2637677B2/ja not_active Expired - Fee Related
- 1993-03-05 SI SI9300108A patent/SI9300108A/sl unknown
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100593117C (zh) * | 2001-04-24 | 2010-03-03 | 阿克西斯-希尔德公司 | 血红蛋白测定 |
| CN101160527B (zh) * | 2005-04-14 | 2013-04-03 | 松下电器产业株式会社 | 血红蛋白衍生物的测定方法、该法中使用的试剂组合物、测定试剂盒、分析设备以及分析系统 |
| US9151765B2 (en) | 2007-10-30 | 2015-10-06 | Panasonic Healthcare Holdings Co., Ltd. | Method for producing agglutinating reagent, agglutinating reagent or product produced thereby, and method for measuring analysis object using the same, and test kit and analysis device |
| CN101755207A (zh) * | 2007-10-30 | 2010-06-23 | 松下电器产业株式会社 | 血红蛋白及血红蛋白衍生物的测定方法、测定试剂盒 |
| CN101755207B (zh) * | 2007-10-30 | 2013-07-31 | 松下电器产业株式会社 | 血红蛋白及血红蛋白衍生物的测定方法、测定试剂盒 |
| US8574913B2 (en) | 2007-10-30 | 2013-11-05 | Panasonic Corporation | Method for measurement of hemoglobin and hemoglobin derivative, and measurement kit |
| CN101493467A (zh) * | 2008-01-25 | 2009-07-29 | 上海伊思柏生物科技有限公司 | 定量测定糖化蛋白质的方法 |
| CN102640002A (zh) * | 2009-05-20 | 2012-08-15 | 瑞莱诊断体系股份有限公司 | 检测糖化血红蛋白百分比的系统和方法 |
| CN102640002B (zh) * | 2009-05-20 | 2015-08-05 | 瑞莱诊断体系股份有限公司 | 检测糖化血红蛋白百分比的系统和方法 |
| CN104062430A (zh) * | 2014-06-30 | 2014-09-24 | 洛阳普莱柯万泰生物技术有限公司 | 一种用于检测样品中流感病毒的试剂盒及其检测方法和应用 |
| CN104062430B (zh) * | 2014-06-30 | 2016-03-30 | 洛阳普莱柯万泰生物技术有限公司 | 一种用于检测样品中流感病毒的试剂盒及其检测方法和应用 |
| CN109154623A (zh) * | 2015-12-30 | 2019-01-04 | P·瓦尔霍 | 用于确定血液样本中的HbA1c的量的方法 |
| CN110702894A (zh) * | 2019-10-10 | 2020-01-17 | 南京欧凯生物科技有限公司 | 一种直接测定糖化血红蛋白含量的检测方法 |
| CN115867805A (zh) * | 2020-03-31 | 2023-03-28 | 乌普卡拉公司 | 用于快速检测生物样品中的目标分析物的装置和方法 |
| CN114441750A (zh) * | 2020-10-30 | 2022-05-06 | 深圳市瑞图生物技术有限公司 | 用于全血样本免疫五项测定的试剂、试剂盒、方法和装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0559164A2 (de) | 1993-09-08 |
| SK14993A3 (en) | 1993-10-06 |
| FI930975L (fi) | 1993-09-06 |
| US5541117A (en) | 1996-07-30 |
| IL104902A0 (en) | 1993-07-08 |
| PT559164E (pt) | 2000-10-31 |
| ZA931533B (en) | 1994-09-04 |
| CA2090981C (en) | 1999-11-16 |
| ATE193378T1 (de) | 2000-06-15 |
| SI9300108A (en) | 1993-09-30 |
| KR930020162A (ko) | 1993-10-19 |
| CZ29193A3 (en) | 1994-01-19 |
| PL297915A1 (en) | 1993-09-06 |
| DE4206932A1 (de) | 1993-09-09 |
| FI930975A0 (fi) | 1993-03-04 |
| JP2637677B2 (ja) | 1997-08-06 |
| DE59310046D1 (de) | 2000-06-29 |
| EP0559164A3 (enExample) | 1994-01-26 |
| HRP930253A2 (en) | 1995-10-31 |
| JPH0611510A (ja) | 1994-01-21 |
| ES2148190T3 (es) | 2000-10-16 |
| NO930770L (no) | 1993-09-06 |
| NZ247054A (en) | 1995-02-24 |
| AU652092B2 (en) | 1994-08-11 |
| NO930770D0 (no) | 1993-03-03 |
| HUT70463A (en) | 1995-10-30 |
| FI930975A7 (fi) | 1993-09-06 |
| EP0559164B1 (de) | 2000-05-24 |
| DK0559164T3 (da) | 2000-10-30 |
| AU3387193A (en) | 1993-09-16 |
| CA2090981A1 (en) | 1993-09-06 |
| HU9300596D0 (en) | 1993-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1081765A (zh) | 用于测定血红蛋白衍生物的免疫方法 | |
| EP0316306B1 (en) | Monoclonal antibodies special for HB A1c | |
| CN110618263B (zh) | 一种c反应蛋白全程检测的方法以及相应的试剂盒 | |
| US4467031A (en) | Enzyme-immunoassay for carcinoembryonic antigen | |
| JPH0720437B2 (ja) | モノクロナ−ル抗体 | |
| WO2014112318A1 (ja) | 検体中のヘモグロビンA1cの免疫測定方法 | |
| EP0455225B1 (en) | Method for measuring the percentage of glycation of a particular protein | |
| AU661207B2 (en) | Simultaneous determination of HbA1c and haemoglobin variants with a glycation analogus to HbA1c | |
| EP0779513B1 (en) | Method for immunological determination of hemoglobin derivative and treating reagent for use therein | |
| JP4214648B2 (ja) | 糖化蛋白質測定試薬 | |
| US10605803B2 (en) | Composition for enzyme immunoassay using immunofluorescence and uses thereof | |
| JP2543630B2 (ja) | 特定タンパク質の糖化割合の測定方法 | |
| CN1182392C (zh) | 便潜血检查方法 | |
| JP7268306B2 (ja) | 生体試料中の測定対象物質を免疫学的に測定する方法 | |
| JP2649016B2 (ja) | 免疫反応干渉作用の除去方法 | |
| JP2000180439A (ja) | 糖化ヘモグロビン測定用全血の前処理方法 | |
| EP0460650A2 (en) | Method for the determination of an analyte | |
| WO2024181457A1 (ja) | 脱糖鎖化ハプトグロビンを用いたヘモグロビンの免疫学的測定方法 | |
| JP4491572B2 (ja) | 酵素免疫測定法による試料中の測定対象物質の測定試薬及び測定方法 | |
| JP2520465B2 (ja) | 多標識抗体 | |
| CN115951072A (zh) | 一种糖化血红蛋白-c肽联合检测试剂盒 | |
| CN118348261A (zh) | 一种igf-ⅰ定量检测试剂盒 | |
| WO2021128065A1 (zh) | 人fgf-23的荧光免疫层析试纸和人fgf-23的荧光免疫层析检测试剂盒 | |
| JPH07140146A (ja) | 安定なペルオキシダーゼ組成物及び安定な抗体組成物 | |
| JPH0775574A (ja) | 安定なペルオキシダーゼ組成物及び安定な抗体組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |